Revolution Medicines, Inc.
RVMD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 16 sales; 693 institutions reported holding it in 13F filings for Q2 2026, worth $40.1B in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesRVMDW
13F holders, Q1 2026
Institutional positions in Revolution Medicines, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 514
- +134 vs. Q4 2025
- Shares held
- 198.3M
- +18.1M (+10.1%) vs. Q4 2025
- Total value
- $19.1B
- +$4.71B (+32.9%) vs. Q4 2025
- New holders
- 172
- 165 more added
- Sold out
- 38
- 127 more reduced
7 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 693 | $40.1B |
| Q1 2026 | 514 | $19.1B |
| Q4 2025 | 387 | $15.9B |
| Q3 2025 | 323 | $8.96B |
| Q2 2025 | 308 | $7.02B |
| Q1 2025 | 284 | $6.83B |
| Q4 2024 | 281 | $8.45B |
| Q3 2024 | 255 | $7.74B |
| Q2 2024 | 223 | $6.54B |
| Q1 2024 | 210 | $5.18B |
| Q4 2023 | 184 | $4.59B |
| Q3 2023 | 168 | $3.11B |
| Q2 2023 | 139 | $2.99B |
| Q1 2023 | 152 | $2.34B |
| Q4 2022 | 135 | $2.10B |
| Q3 2022 | 142 | $1.74B |
| Q2 2022 | 135 | $1.49B |
| Q1 2022 | 126 | $1.89B |
| Q4 2021 | 117 | $1.85B |
| Q3 2021 | 114 | $1.99B |
| Q2 2021 | 130 | $2.23B |
| Q1 2021 | 128 | $3.05B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Revolution Medicines, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Farallon Capital Management, L.L.C. | 13,604,796 | $1.32B | 7.84% | −978,000−6.7% | Reduced |
| BlackRock, Inc. | 11,212,706 | $1.09B | 0.02% | +2,286,050+25.6% | Added |
| Janus Henderson Group PLC | 9,766,496 | $949.5M | 0.45% | −2,537,006−20.6% | Reduced |
| Baker Bros. Advisors LP | 9,555,357 | $929.3M | 5.34% | +100,000+1.1% | Added |
| FMR LLC | 8,464,314 | $823.2M | 0.04% | −123,667−1.4% | Reduced |
| Vanguard Capital Management LLC | 8,362,284 | $813.2M | 0.02% | +8,362,284 | New |
| Nextech Invest, Ltd. | 7,601,087 | $739.2M | 52.02% | 00.0% | Unchanged |
| Vanguard Portfolio Management LLC | 7,502,623 | $729.6M | 0.04% | +7,502,623 | New |
| Paradigm Biocapital Advisors LP | 6,655,703 | $647.3M | 13.23% | +11,300+0.2% | Added |
| Wellington Management Group LLP | 6,027,819 | $586.2M | 0.11% | −959,820−13.7% | Reduced |
| Adage Capital Partners GP, L.L.C. | 5,475,611 | $532.5M | 0.82% | +3,270,056+148.3% | Added |
| State Street Corp | 4,402,662 | $428.2M | 0.01% | +293,372+7.1% | Added |
| UBS Group AG | 4,386,791 | $426.6M | 0.08% | +1,298,854+42.1% | Added |
| Geode Capital Management, LLC | 3,338,142 | $323.9M | 0.02% | +176,179+5.6% | Added |
| Alphabet Inc. | 3,292,525 | $320.2M | 7.97% | −52,577−1.6% | Reduced |
| Price T Rowe Associates Inc | 3,232,213 | $314.3M | 0.04% | −172,504−5.1% | Reduced |
| BVF Inc | 2,856,782 | $277.8M | 8.85% | −500,000−14.9% | Reduced |
| Casdin Capital, LLC | 2,577,333 | $250.6M | 18.98% | 00.0% | Unchanged |
| Woodline Partners LP | 2,506,570 | $243.8M | 0.92% | +5,675+0.2% | Added |
| Holocene Advisors, LP | 2,468,644 | $240.1M | 0.58% | +560,696+29.4% | Added |
| Vestal Point Capital, LP | 2,375,000 | $231.0M | 6.46% | +2,080,000+705.1% | Added |
| Avoro Capital Advisors LLC | 2,344,444 | $228.0M | 2.25% | +174,444+8.0% | Added |
| Deerfield Management Company, L.P. (Series C) | 2,297,000 | $223.4M | 2.64% | −597,613−20.6% | Reduced |
| Goldman Sachs Group Inc | 2,185,500 | $212.5M | 0.03% | −306,083−12.3% | Reduced |
| Darwin Global Management, Ltd. | 2,211,018 | $205.0M | 5.44% | +2,211,018 | New |
| Logos Global Management LP | 2,000,000 | $194.5M | 10.02% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 1,885,821 | $183.4M | 0.52% | +1,646,724+688.7% | Added |
| National Bank of Canada | 1,749,000 | $170.1M | 0.17% | +1,749,000 | New |
| Charles Schwab Investment Management Inc | 1,735,476 | $168.8M | 0.03% | +51,747+3.1% | Added |
| Caligan Partners LP | 1,652,808 | $160.7M | 11.37% | +368,908+28.7% | Added |
| Ameriprise Financial Inc | 1,579,793 | $153.6M | 0.04% | −477,064−23.2% | Reduced |
| Two Sigma Investments, LP | 1,558,807 | $151.6M | 0.13% | +1,137,072+269.6% | Added |
| Westfield Capital Management Co LP | 1,556,578 | $151.4M | 0.64% | −1,288,435−45.3% | Reduced |
| Bellevue Group AG | 1,544,456 | $150.2M | 3.57% | −3,461,263−69.1% | Reduced |
| Integral Health Asset Management, LLC | 1,500,000 | $145.9M | 7.72% | +300,000+25.0% | Added |
| Rock Springs Capital Management LP | 1,209,465 | $117.6M | 6.93% | −125,805−9.4% | Reduced |
| Polar Capital Holdings Plc | 1,133,930 | $110.3M | 0.48% | −879,861−43.7% | Reduced |
| Franklin Resources Inc | 1,133,546 | $110.2M | 0.03% | +73,375+6.9% | Added |
| Vanguard Fiduciary Trust Co | 1,133,319 | $110.2M | 0.03% | +1,133,319 | New |
| Siren, L.L.C. | 1,110,980 | $108.0M | 3.00% | −224,095−16.8% | Reduced |
| D. E. Shaw & Co., Inc. | 1,022,298 | $99.4M | 0.08% | −591,432−36.6% | Reduced |
| Northern Trust Corp | 954,256 | $92.8M | 0.01% | +103,933+12.2% | Added |
| AH Capital Management, L.L.C. | 921,099 | $89.6M | 6.94% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 844,614 | $82.1M | 0.02% | −317,032−27.3% | Reduced |
| AIHC Capital Management Ltd | 828,974 | $80.6M | 67.37% | −71,418−7.9% | Reduced |
| MIC Capital Management UK LLP | 795,733 | $77.4M | 21.95% | +287,164+56.5% | Added |
| General Atlantic LLC | 707,791 | $68.8M | 3.20% | −2,105,137−74.8% | Reduced |
| Morgan Stanley | 705,793 | $68.6M | 0.00% | +54,061+8.3% | Added |
| Nearwater Capital Markets, Ltd | 678,000 | $65.9M | 1.56% | +678,000 | New |
| Frazier Life Sciences Management, L.P. | 675,686 | $65.7M | 1.69% | −121,769−15.3% | Reduced |
| T. Rowe Price Investment Management, Inc. | 664,047 | $64.6M | 0.04% | −1,536,329−69.8% | Reduced |
| Bank of New York Mellon Corp | 635,366 | $61.8M | 0.01% | +93,297+17.2% | Added |
| Worldquant Millennium Advisors LLC | 622,304 | $60.5M | 0.23% | +528,294+562.0% | Added |
| Bank of America Corp | 614,157 | $59.7M | 0.00% | −265,688−30.2% | Reduced |
| DAFNA Capital Management LLC | 580,678 | $56.5M | 12.85% | −23,836−3.9% | Reduced |
| Candriam Luxembourg S.C.A. | 580,677 | $56.5M | 0.29% | −450,315−43.7% | Reduced |
| TCG Crossover Management, LLC | 576,473 | $56.1M | 1.60% | +140,000+32.1% | Added |
| Qube Research & Technologies Ltd | 553,290 | $53.8M | 0.08% | +553,290 | New |
| Pictet Asset Management Holding SA | 557,560 | $53.6M | 0.06% | −579,561−51.0% | Reduced |
| Lunate Capital Ltd | 549,050 | $53.4M | 44.36% | −1,647,150−75.0% | Reduced |
| MPM Oncology Impact Management LP | 506,776 | $49.3M | 3.81% | +1,104+0.2% | Added |
| UBS Asset Management Americas Inc | 500,595 | $48.7M | 0.01% | +151,183+43.3% | Added |
| Boxer Capital Management, LLC | 500,000 | $48.6M | 6.38% | +100,000+25.0% | Added |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 479,080 | $46.6M | 3.95% | +479,080 | New |
| First Turn Management, LLC | 468,376 | $45.5M | 5.09% | −170,009−26.6% | Reduced |
| Deutsche Bank AG | 465,758 | $45.3M | 0.01% | +433,541+1,345.7% | Added |
| Boothbay Fund Management, LLC | 438,595 | $42.7M | 1.00% | +111,443+34.1% | Added |
| Swiss National Bank | 425,431 | $41.4M | 0.02% | +149,100+54.0% | Added |
| BNP Paribas Arbitrage, SA | 422,443 | $41.1M | 0.03% | −196,944−31.8% | Reduced |
| Citadel Advisors LLC | 400,053 | $38.9M | 0.03% | −902,308−69.3% | Reduced |
| Invesco Ltd. | 392,844 | $38.2M | 0.00% | +24,993+6.8% | Added |
| Barclays PLC | 383,179 | $37.3M | 0.01% | +247,131+181.6% | Added |
| Millennium Management LLC | 377,332 | $36.7M | 0.03% | −422,786−52.8% | Reduced |
| Samlyn Capital, LLC | 371,948 | $36.2M | 0.62% | +371,948 | New |
| Royal Bank of Canada | 371,743 | $36.2M | 0.01% | −131,978−26.2% | Reduced |
| Voloridge Investment Management, LLC | 368,325 | $35.8M | 0.14% | +46,036+14.3% | Added |
| Mass General Brigham, Inc | 344,091 | $33.5M | 7.14% | 00.0% | Unchanged |
| Legal & General Group Plc | 341,148 | $33.2M | 0.01% | +187,768+122.4% | Added |
| Nuveen, LLC | 340,611 | $33.1M | 0.01% | −65,630−16.2% | Reduced |
| American Century Companies Inc | 335,528 | $32.6M | 0.02% | −131,832−28.2% | Reduced |
| TD Asset Management Inc | 317,811 | $30.9M | 0.03% | −52,709−14.2% | Reduced |
| Defilade Capital Management, L.P. | 315,972 | $30.7M | 4.31% | −47,482−13.1% | Reduced |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 315,860 | $30.7M | 1.05% | +315,860 | New |
| Jennison Associates LLC | 307,377 | $29.9M | 0.02% | +2,117+0.7% | Added |
| JPMorgan Chase & Co | 301,393 | $27.9M | 0.00% | −120,234−28.5% | Reduced |
| California Public Employees Retirement System | 281,960 | $27.4M | 0.02% | −9,046−3.1% | Reduced |
| StemPoint Capital LP | 281,632 | $27.4M | 5.26% | +219,600+354.0% | Added |
| Man Group plc | 275,270 | $26.8M | 0.06% | +177,765+182.3% | Added |
| Sumitomo Mitsui Trust Holdings, Inc. | 270,972 | $26.4M | 0.02% | +265,474+4,828.6% | Added |
| Melqart Asset Management (UK) Ltd | 270,363 | $26.3M | 2.59% | +270,363 | New |
| Checkpoint Capital L.P. | 262,539 | $25.5M | 9.16% | −107,461−29.0% | Reduced |
| Eventide Asset Management, LLC | 261,425 | $25.4M | 0.42% | −116,836−30.9% | Reduced |
| Nicholas Investment Partners, LP | 261,166 | $25.4M | 1.83% | −56,545−17.8% | Reduced |
| Perceptive Advisors LLC | 258,600 | $25.1M | 0.50% | +258,600 | New |
| Trails Edge Capital Partners, LP | 245,000 | $23.8M | 5.61% | +245,000 | New |
| Frontier Capital Management Co LLC | 243,804 | $23.7M | 0.24% | −186,964−43.4% | Reduced |
| Ensign Peak Advisors, Inc | 227,940 | $22.2M | 0.04% | −7,868−3.3% | Reduced |
| Marsico Capital Management LLC | 219,460 | $21.3M | 0.63% | 00.0% | Unchanged |
| Marshall Wace, LLP | 216,661 | $21.1M | 0.02% | −169,530−43.9% | Reduced |
| Fisher Asset Management, LLC | 215,947 | $21.0M | 0.01% | −25,110−10.4% | Reduced |